The rapid increase of chemicals production in China, wider Asia, Latin America and the Middle East is making capacity in established regions redundant or under-utilized. This trend is fueling industry merger and acquisition (M&A) activity as much as the drive by firms to gain market share. It's being seen as a shaper of the U.S. industry in particular. M&A experts Lorelli Consulting, for instance have asked whether the glass is half full or half empty for sellers and buyers. In many cases, the answer is something of a surprise. For example, excess capacity is a serious problem for one firm but an opportunity for another. For a seller, this is the silver lining. Lorelli says "acquire and rationalize" may be the strategy behind a deal. Significant synergy opportunities to the seller can translate into a higher price a price higher than the business is worth on a stand-alone basis. Lorelli says: In one chemicals transaction currently being considered, the seller's earnings are conservatively projected to increase by more than 50 percent if the buyer makes the acquisition and moves production to its own location. There is also the real estate value of the facility. This value is not always immediately apparent given potential environmental liabilities, but assets are an important consideration for some. The problems faced by producers also make U.S. businesses attractive for competitors keen to widen market share and gain a foothold in new businesses. There are barriers to change, but chemicals M&A is widening to include players from outside the usual triad of North America, Japan and Europe. Those keen to gain a foothold in established markets and buy market access for their products are looking at many different ways to achieve their aims. Strong growth in young markets is one thing, but steady growth in a well-established market is another. And industrial buyers, alongside some private equity firms, are prepared to pay higher premiums for the right businesses.